Rhinosinusitis and sinusitis describe the same condition. Rhinosinusitis is the medically preferred term because sinus inflammation almost always occurs simultaneously with nasal cavity inflammation, making “sinusitis” alone anatomically incomplete. The European Position Paper on Rhinosinusitis (EPOS2012), the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNS), the American Rhinologic Society and the American Academy of Otolaryngic Allergy all replaced sinusitis with rhinosinusitis for this reason.
Rhinosinusitis accounts for approximately 30 million primary care visits annually in the United States alone, according to StatPearls (Kwon, Hathaway and Sutton, 2025). Direct medical costs exceed $5.8 billion annually in the US. Despite the clinical scale of the condition, terminology confusion between rhinosinusitis, sinusitis and rhinitis remains common among patients. This article defines each term, explains the anatomical reason the term changed, clarifies how rhinitis differs from rhinosinusitis, and outlines evidence-based treatment options including Nasodren®, the only natural nasal spray with a Level A recommendation in European rhinosinusitis guidelines.
What Is the Difference Between Sinusitis and Rhinosinusitis?
Rhinosinusitis and sinusitis refer to the same inflammatory condition of the paranasal sinuses. Rhinosinusitis is the medically accurate term because sinus inflammation almost always involves simultaneous nasal mucosa inflammation. Four major international clinical guideline bodies have replaced sinusitis with rhinosinusitis.
The anatomical basis for the terminology change is structural. The nasal mucosa is directly contiguous with the mucosal lining of the paranasal sinuses. The nasal middle turbinate extends directly into the ethmoid sinuses, meaning mucosal inflammation initiated in the nasal cavity propagates into the sinus cavities along the same tissue layer. Richard M. Rosenfeld, Professor and Chairman of Otolaryngology at SUNY Downstate Medical Center in Brooklyn and Chair of the AAO-HNS Guidelines Panel, confirmed this in the AAO-HNS guideline statement: “The term rhinosinusitis is preferred because sinusitis is almost always accompanied by inflammation of the contiguous nasal mucosa.” The American Academy of Family Physicians (AAFP) concurs, stating in its 2016 clinical review in American Family Physician: “Because the nasal mucosa is contiguous with mucosa of the paranasal sinuses, inflammation of the sinuses rarely occurs without inflammation of the nasal mucosa.”
Clinically, purulent sinus disease without concurrent nasal cavity inflammation is rare. CT imaging studies have established that the mucosal linings of the nose and sinuses are simultaneously involved even during the common cold, a condition previously thought to affect only the nasal passages. This evidence, reviewed by Boston Medical Center otolaryngologists, provided the catalyst for adopting rhinosinusitis as the standard term.
Why Did Medicine Change from Sinusitis to Rhinosinusitis?
Medicine replaced “sinusitis” with “rhinosinusitis” through a documented progression of 4 international guideline events between 1997 and 2012.
- Pre-1997: “Sinusitis” was the universal term, referring only to inflammation or infection of the sinus cavities, without explicit acknowledgement of simultaneous nasal mucosal involvement.
- 1997: David C. Lanza and David W. Kennedy published the AAO-HNS Rhinosinusitis Task Force diagnostic criteria, formally introducing “rhinosinusitis” into international clinical nomenclature for the first time.
- EP3OS 2007 (European Position Paper on Rhinosinusitis and Nasal Polyps, 3rd edition, PubMed ID: 17844873): The EPOS working group formally defined rhinosinusitis as “inflammation of the nose and the paranasal sinuses,” stating: “Rhinitis and sinusitis usually coexist and are concurrent in most individuals; thus, the correct terminology is now rhinosinusitis.”
- EPOS2012: Confirmed the EPOS2007 definition and expanded clinical guidance. EPOS2012 included Nasodren® (Cyclamen europaeum extract nasal spray) with a Level A recommendation, the only natural nasal spray to receive this designation.
The expert panels that adopted rhinosinusitis acknowledged one important caveat. According to PMC3084646 (Hastan, Fokkens, Bachert et al., published in Rhinology), “the expert panels acknowledged that the terms rhinosinusitis and sinusitis should be used interchangeably, especially because the term rhinosinusitis has only come into common use during the past decade.” In clinical settings and patient communication, sinusitis remains widely accepted. The terminological difference carries no diagnostic or treatment implication.
Are Sinusitis and Rhinosinusitis Exactly the Same Condition?
Yes. Sinusitis and rhinosinusitis describe the same disease. The difference is terminological, not clinical.
3 nuance points clarify the relationship completely. First, in terms of anatomical scope: “sinusitis” technically refers only to sinus cavity inflammation, while “rhinosinusitis” explicitly names both the nasal mucosa and the paranasal sinuses. In practice, both produce the same 4 cardinal symptoms defined by EPOS2012: nasal blockage, nasal discharge (rhinorrhea), facial pain or pressure, and reduction or loss of smell (hyposmia or anosmia).
Second, in terms of guideline usage: EPOS2012 uses rhinosinusitis exclusively throughout its diagnostic criteria and treatment recommendations. The AAO-HNS Clinical Practice Guideline for Adult Sinusitis (CPG:AS) uses rhinosinusitis in its formal definitions. General practitioners, patients and everyday medical communication continue to use sinusitis. Both terms are accepted.
Third, in terms of clinical implications: diagnostic criteria, imaging thresholds, treatment decisions and symptom monitoring are identical regardless of which term is used. Rhinosinusitis is not a more severe or different version of sinusitis. It is the same condition with a more anatomically complete name. One competitor page incorrectly states that rhinosinusitis describes “a more severe and chronic form of sinusitis.” This claim is factually incorrect and contradicts all major clinical guidelines.
What Is the Difference Between Rhinitis, Sinusitis and Rhinosinusitis?
Rhinitis and rhinosinusitis are 3 distinct medical terms that are frequently confused. Rhinitis refers to nasal mucosa inflammation only. Sinusitis and rhinosinusitis refer to inflammation of both the nasal mucosa and the paranasal sinuses simultaneously. Rhinosinusitis is not a synonym for rhinitis.
Rhinitis is inflammation of the nasal mucous membranes without sinus cavity involvement. The hallmark symptoms of rhinitis are sneezing, nasal pruritus (itching), clear watery nasal discharge and congestion. Rhinitis does not produce facial pain, facial pressure or significant loss of smell, because the paranasal sinuses are not involved. Rhinitis is caused by allergens (allergic rhinitis, including hay fever), viral infection, irritants, hormonal changes or medications. Rhinitis is classified into allergic rhinitis and non-allergic rhinitis.
Rhinosinusitis (sinusitis) is inflammation of both the nasal mucosa and the paranasal sinuses. It produces the 4 cardinal symptoms of EPOS2012: nasal blockage, rhinorrhea (anterior or posterior), facial pain or pressure, and hyposmia or anosmia. The presence of facial pain and mucopurulent (thick, coloured) nasal discharge distinguishes rhinosinusitis from rhinitis. As stated in PMC7123453 (University of South Florida Morsani College of Medicine, Joy McCann Culverhouse Chair in Allergy and Immunology): “Rhinosinusitis is often confused with rhinitis, a term usually synonymous with sinusitis. Rhinosinusitis indicates that the nose and the sinuses are affected. Typically, infectious rhinitis secondary to a viral upper respiratory tract infection precedes infectious rhinosinusitis.”
The following table compares the 3 conditions across 7 clinically relevant attributes.
| Feature | Rhinitis | Rhinosinusitis (Sinusitis) |
|---|---|---|
| Location | Nasal mucosa only | Nasal mucosa + paranasal sinuses |
| Facial pain or pressure | No | Yes (cardinal symptom, EPOS2012) |
| Loss of smell | Rare or mild | Common (EPOS2012 cardinal symptom) |
| Nasal discharge | Clear, watery | Thick, mucopurulent |
| Sneezing | Common, prominent | Less common |
| Primary triggers | Allergens, irritants | Viral infection (90-98% of cases) |
| Guideline term (EPOS2012) | Allergic rhinitis / non-allergic rhinitis | Rhinosinusitis |
The “rhino-” prefix in rhinosinusitis does not make rhinosinusitis a form of rhinitis. The prefix indicates that the nasal cavity (rhinion) is simultaneously involved alongside the sinuses. Rhinitis and rhinosinusitis are different diagnoses with different treatment pathways.
Can Rhinitis Lead to Rhinosinusitis?
Yes. Rhinitis frequently precedes rhinosinusitis through a 4-step mechanism.
- An allergen or viral trigger causes nasal mucosal inflammation (rhinitis), producing oedema in the nasal lining.
- Mucosal oedema narrows and then occludes the sinus ostia within the ostiomeatal complex (OMC), the primary drainage junction between the sinuses and nasal cavity.
- Normal sinus drainage is blocked, causing mucus to accumulate inside the paranasal sinuses.
- Stagnant mucus creates anaerobic conditions favouring viral or bacterial multiplication, establishing rhinosinusitis.
Allergic rhinitis is identified in up to 60-80% of patients with chronic rhinosinusitis, according to research published in Frontiers in Allergy (2021). The University of South Florida study (PMC7123453) confirms that “poorly controlled rhinitis is a significant cause of impaired quality of life” and that appropriate management of rhinitis is “essential to optimally control asthma and sleep apnea.”
Treating rhinitis effectively, through antihistamines, intranasal corticosteroids or allergen immunotherapy, reduces rhinosinusitis recurrence frequency by preventing the ostiomeatal complex obstruction that allows rhinosinusitis to develop. When rhinitis has already progressed to rhinosinusitis, Nasodren® (Cyclamen europaeum nasal spray) restores mucociliary clearance and drains the blocked paranasal sinuses, addressing the rhinosinusitis that rhinitis initiated.
How Is Rhinosinusitis Classified?
Rhinosinusitis is classified by symptom duration into 4 subtypes, as defined by EPOS2012 and the AAO-HNS Clinical Practice Guideline for Adult Sinusitis.
- Acute rhinosinusitis (ARS): sudden onset of rhinosinusitis symptoms lasting less than 4 weeks, with complete symptom resolution. Viral infection causes 90-98% of ARS cases in adults.
- Subacute rhinosinusitis: symptoms persisting 4-12 weeks, representing the continuum between acute and chronic rhinosinusitis.
- Chronic rhinosinusitis (CRS): symptoms lasting 12 weeks or more despite medical treatment. CRS is classified into CRSwNP (with nasal polyps, eosinophilic inflammation) and CRSsNP (without nasal polyps, often biofilm-driven).
- Recurrent acute rhinosinusitis (RARS): 4 or more episodes per year, each lasting at least 10 days, with complete symptom resolution between episodes.
Classification by cause identifies 5 subtypes. Viral rhinosinusitis (VRS) accounts for 90-98% of acute cases. Post-viral rhinosinusitis (PVRS) is the most common form of acute rhinosinusitis, occurring when symptoms persist more than 10 days without worsening after a viral infection. Acute bacterial rhinosinusitis (ABRS) develops in 0.5-2% of VRS cases in adults. Chronic rhinosinusitis with nasal polyps (CRSwNP) involves eosinophilic type 2 inflammation and is associated with asthma and NSAID sensitivity. Chronic rhinosinusitis without nasal polyps (CRSsNP) is more often driven by bacterial biofilm formation and anatomical obstruction.
The classification criteria are identical regardless of whether the term “sinusitis” or “rhinosinusitis” is used. Acute sinusitis and acute rhinosinusitis describe the same clinical entity using different terminology.
What Are the Symptoms of Rhinosinusitis?
The 4 cardinal symptoms of rhinosinusitis, as defined by EPOS2012, are nasal blockage, nasal discharge (rhinorrhea), facial pain or pressure, and reduction or loss of smell. EPOS2012 requires at least 2 of these symptoms for rhinosinusitis diagnosis, with nasal blockage or rhinorrhea being mandatory in one of the 2.
- Nasal blockage or congestion: obstruction of nasal airflow caused by mucosal oedema from sinus inflammation, not simply excess mucus. Severity ranges from mild stuffiness to complete bilateral nasal obstruction.
- Nasal discharge (rhinorrhea): anterior rhinorrhea flows from the nostrils; posterior rhinorrhea (post-nasal drip) drains down the back of the throat, producing cough, throat irritation and bad breath.
- Facial pain or pressure: caused by trigeminal nerve stimulation from inflammatory mediators (bradykinin, prostaglandins) and mechanical pressure from retained mucus. Location indicates the affected sinus: cheek pain (maxillary), forehead pain (frontal), pain between eyes (ethmoid), deep pain behind eyes (sphenoid).
- Reduction or loss of smell (hyposmia or anosmia): from physical obstruction of airflow to the olfactory epithelium and inflammatory oedema of the olfactory mucosa. Most pronounced in chronic rhinosinusitis with nasal polyps (CRSwNP).
Additional symptoms of rhinosinusitis include headache, bad breath (halitosis from mucopurulent mucus), cough from post-nasal drip, ear fullness (from Eustachian tube obstruction), fever (in bacterial rhinosinusitis only), fatigue and altered taste. These symptoms are identical regardless of whether the condition is called sinusitis or rhinosinusitis.
How Is Rhinosinusitis Diagnosed?
Rhinosinusitis is diagnosed clinically using the same criteria whether the condition is labelled sinusitis or rhinosinusitis. EPOS2012 requires at least 2 cardinal symptoms (including nasal blockage or rhinorrhea) lasting 7-10 days for acute rhinosinusitis, or 12 weeks for chronic rhinosinusitis.
- Clinical history: symptom duration, character (nasal blockage, rhinorrhea, facial pain, smell loss), prior episodes, and triggering events (recent viral upper respiratory tract infection, allergy season, dental treatment, water sports).
- Physical examination: anterior rhinoscopy using nasal speculum or otoscope; palpation of sinus areas for tenderness; oropharyngeal examination for post-nasal drip. Sinus transillumination provides supportive data with 60% reproducibility for assessing maxillary sinus fluid.
- Nasal endoscopy (ENT referral): the gold standard for structural assessment. Identifies mucopurulent discharge from the middle meatus, mucosal oedema, nasal polyps and ostiomeatal complex obstruction directly.
- CT scan (non-contrast): preferred imaging for chronic or refractory rhinosinusitis, quantified using the Lund-Mackay scoring system. CT is not indicated for a first episode of uncomplicated acute rhinosinusitis (EPOS2012). MRI is reserved for suspected tumour or fungal rhinosinusitis.
Diagnostic criteria, imaging thresholds and treatment decisions are the same for sinusitis and rhinosinusitis. The terminological difference carries no diagnostic implication in clinical practice. For patients assessing their own symptoms, Nasodren® provides a free online rhinosinusitis symptom self-assessment developed with ENT specialist input.
How Is Rhinosinusitis Treated?
Treatment of rhinosinusitis follows the same evidence-based approach whether the condition is labelled sinusitis or rhinosinusitis. The treatment spectrum ranges from watchful waiting to surgical intervention, depending on subtype, cause and severity.
Watchful waiting: EPOS2012 recommends watchful waiting as the first-line approach for viral acute rhinosinusitis. Viral ARS resolves without treatment in 7-10 days for 90% or more of patients.
Natural and non-pharmacological treatment:
Nasodren® (Cyclamen europaeum extract nasal spray, 50mg lyophilized) is the only natural nasal spray included in EPOS2012 European rhinosinusitis guidelines, with a Level A recommendation. Nasodren® is classified as an EU Medical Device Class IIA under Regulation 2017/745 (Certificate 0040/MDR EU 2017/745). Cyclamen europaeum saponins stimulate trigeminal nerve receptors in the nasal vestibule, triggering a secretomotor reflex that opens blocked sinus ostia, activates mucociliary clearance and actively drains mucus from all paranasal sinuses. The saponins do not enter the bloodstream. Nasodren® is applied once daily; 90% of patients restore normal paranasal sinus function within 7 days. The treatment produces no rebound congestion, unlike oxymetazoline-based decongestant sprays. The formulation is preservative-free. Nasodren® has been evaluated in over 30 published randomised controlled trials, with results published in Rhinology and The Laryngoscope. Nasodren® is approved for use in children aged 5 and above and has published clinical evidence for otitis media through its effect on Eustachian tube function.
- Saline nasal irrigation: maintains nasal hygiene; produces minimal penetration into the paranasal sinuses; complementary hygiene measure rather than a rhinosinusitis treatment.
- Steam inhalation: provides temporary symptomatic relief through nasal humidification; limited published evidence as a rhinosinusitis treatment.
Pharmacological treatment:
- Intranasal corticosteroids (fluticasone, mometasone, budesonide): first-line for chronic rhinosinusitis and allergic rhinosinusitis; reduce mucosal inflammation.
- Nasal decongestants (oxymetazoline, xylometazoline): maximum 3 consecutive days; rebound congestion (rhinitis medicamentosa) risk with prolonged use.
- Antibiotics: amoxicillin-clavulanate is first-line for acute bacterial rhinosinusitis; indicated in 0.5-2% of rhinosinusitis cases.
- Biologics (dupilumab, omalizumab): for CRSwNP refractory to intranasal corticosteroids.
Surgical treatment:
- FESS (Functional Endoscopic Sinus Surgery): for medically refractory CRS; opens sinus drainage pathways under endoscopic guidance.
- Balloon sinuplasty: minimally invasive ostial dilation.
- Septoplasty: for deviated nasal septum causing recurrent rhinosinusitis.
Treatment guidelines for rhinosinusitis (EPOS2012) and sinusitis (AAO-HNS CPG:AS) are aligned. The terminological difference between sinusitis and rhinosinusitis does not change any treatment decision.
Frequently Asked Questions: Sinusitis vs Rhinosinusitis
Is rhinosinusitis the same as sinusitis?
Yes. Rhinosinusitis and sinusitis describe the same disease. Rhinosinusitis is the medically preferred term adopted by EPOS2012 and the AAO-HNS because sinus inflammation almost always involves simultaneous nasal cavity inflammation. The terms are used interchangeably in clinical practice.
Why do doctors say rhinosinusitis instead of sinusitis?
Rhinosinusitis is anatomically more accurate. The nasal mucosa is directly contiguous with sinus mucosa, and the nasal middle turbinate extends into the ethmoid sinuses. Purulent sinus disease without concurrent nasal mucosal inflammation is rare. Four major guideline bodies (EPOS, AAO-HNS, ARS, AAOA) adopted rhinosinusitis for this anatomical reason.
What is the difference between rhinitis, sinusitis and rhinosinusitis?
Rhinitis is nasal mucosa inflammation only, producing sneezing, itching and clear nasal discharge without facial pain or paranasal sinus involvement. Sinusitis and rhinosinusitis describe inflammation of both the nasal mucosa and the paranasal sinuses, producing nasal blockage, facial pain, mucopurulent discharge and loss of smell. The “rhino-” prefix in rhinosinusitis does not make it rhinitis.
Is rhinosinusitis more serious than sinusitis?
No. Rhinosinusitis and sinusitis are the same condition with different terminology. Rhinosinusitis is not a more severe or advanced form of sinusitis. The same EPOS2012 classification criteria (acute, subacute, chronic, recurrent) and the same treatment guidelines apply to both terms identically.
Can you have rhinitis without sinusitis?
Yes. Rhinitis (nasal inflammation) can occur without sinusitis, particularly in early-stage allergic rhinitis before nasal oedema blocks the sinus ostia. However, poorly controlled rhinitis frequently progresses to rhinosinusitis when nasal inflammation obstructs the ostiomeatal complex.
What is acute rhinosinusitis?
Acute rhinosinusitis is sudden-onset rhinosinusitis lasting less than 4 weeks, caused by viral infection in 90-98% of cases in adults. EPOS2012 requires at least 2 of the 4 cardinal symptoms, with nasal blockage or rhinorrhea being mandatory. “Acute sinusitis” and “acute rhinosinusitis” are the same diagnosis.
Is rhinosinusitis contagious?
Rhinosinusitis itself is not contagious. The viral infection (common cold) that triggers most rhinosinusitis cases spreads through respiratory droplets and contaminated surfaces. Bacterial pathogens associated with rhinosinusitis, including Streptococcus pneumoniae and Haemophilus influenzae, can spread through close contact with an infected individual.
Rhinosinusitis and Sinusitis: The Same Condition, the Right Treatment
Rhinosinusitis and sinusitis are the same inflammatory condition of the nasal mucosa and paranasal sinuses. Rhinosinusitis is the preferred medical term in EPOS2012 and AAO-HNS guidelines because the nasal mucosa and sinus mucosa are contiguous, and isolated sinus inflammation without concurrent nasal mucosal involvement is anatomically rare. Rhinitis is a distinct, separate condition involving the nasal mucosa only, without paranasal sinus involvement. The terminological difference between sinusitis and rhinosinusitis carries no diagnostic or treatment implication: classification criteria, diagnostic thresholds and treatment decisions are identical for both terms.
For rhinosinusitis treatment, Nasodren® (Cyclamen europaeum nasal spray) is the only natural treatment with a Level A recommendation in European EPOS2012 rhinosinusitis guidelines — the same guidelines that established rhinosinusitis as the standard medical terminology. Nasodren® has been evaluated in over 30 randomised controlled trials, is classified as an EU Medical Device Class IIA, and restores normal paranasal sinus function in 90% of patients within 7 days of treatment initiation.